Home

Latest News

12345678910
3 of Wall Street’s Favorite Stocks with Open Questions
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · July 10, 2025
India Markets Muted Ahead Of Expiry, All Eyes On TCS Earnings; SEBI RAs Eye 25,600 As Key Nifty Resistancestocktwits.com
Pharma lagged; metals and energy stocks saw some buying. Retail sentiment also turned neutral on the Nifty.
Via Stocktwits · July 10, 2025
Amazon Prime Day 2025 Sees Mixed Response On Day 1: Retail Traders Still Upbeatstocktwits.com
Prime Day runs from July 8 to July 11 and overlaps with multiday sales offered by Walmart and Target.
Via Stocktwits · July 10, 2025
Trump Appoints Transportation Secretary Sean Duffy As Interim NASA Administratorbenzinga.com
Trump appoints Sec. Sean Duffy as interim NASA Administrator, praising his work in transportation amid Elon Musk feud.
Via Benzinga · July 10, 2025
This Hidden Trap Could Cost You A Fortunetalkmarkets.com
Something’s wrong on the charts tonight…It’s not that obvious, but this *hidden* clue tells me TRAPS are likely where the money is made (or lost) tomorrow morning!
Via Talk Markets · July 10, 2025
Google Rejected Perplexity's Request To Become A Default Search Engine Option On Chrome: AI Startup Fires Back With 'Comet' Browserbenzinga.com
Perplexity AI launched its Comet web browser after Google Chrome rejected the startup's offer to become a default search engine option.
Via Benzinga · July 10, 2025
3 Reasons to Sell DDD and 1 Stock to Buy Instead
Shareholders of 3D Systems would probably like to forget the past six months even happened. The stock dropped 44.8% and now trades at $1.80. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Via StockStory · July 10, 2025
2 Reasons to Watch AGL and 1 to Stay Cautious
Over the last six months, agilon health’s shares have sunk to $2.30, producing a disappointing 5.3% loss - a stark contrast to the S&P 500’s 7.5% gain. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Via StockStory · July 10, 2025
3 Reasons to Avoid UTI and 1 Stock to Buy Instead
Universal Technical Institute currently trades at $31.80 and has been a dream stock for shareholders. It’s returned 402% since July 2020, blowing past the S&P 500’s 96.5% gain. The company has also beaten the index over the past six months as its stock price is up 28.4% thanks to its solid quarterly results.
Via StockStory · July 10, 2025
3 Big Reasons to Love Atlassian (TEAM)
Over the past six months, Atlassian’s shares (currently trading at $220.40) have posted a disappointing 9.1% loss, well below the S&P 500’s 7.5% gain. This might have investors contemplating their next move.
Via StockStory · July 10, 2025
3 Reasons to Avoid LASR and 1 Stock to Buy Instead
nLIGHT has been on fire lately. In the past six months alone, the company’s stock price has rocketed 67.9%, reaching $18.70 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Via StockStory · July 10, 2025
3 Reasons MET is Risky and 1 Stock to Buy Instead
Since January 2025, MetLife has been in a holding pattern, posting a small loss of 2.5% while floating around $78.24. The stock also fell short of the S&P 500’s 7.5% gain during that period.
Via StockStory · July 10, 2025
Pangaea (PANL): Buy, Sell, or Hold Post Q1 Earnings?
Pangaea currently trades at $5.19 per share and has shown little upside over the past six months, posting a small loss of 4.4%. The stock also fell short of the S&P 500’s 7.5% gain during that period.
Via StockStory · July 10, 2025
3 Reasons to Sell GDYN and 1 Stock to Buy Instead
What a brutal six months it’s been for Grid Dynamics. The stock has dropped 41.7% and now trades at $11.85, rattling many shareholders. This may have investors wondering how to approach the situation.
Via StockStory · July 10, 2025
PennyMac Financial Services (PFSI): Buy, Sell, or Hold Post Q1 Earnings?
PennyMac Financial Services has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 6.3% to $102.29 per share while the index has gained 7.5%.
Via StockStory · July 10, 2025
2 Reasons to Like GABC (and 1 Not So Much)
German American Bancorp has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.4% to $40.89 per share while the index has gained 7.5%.
Via StockStory · July 10, 2025
Elizabeth Warren Says Critical That Trump's 'Superhighway Of Crypto Corruption' Be Shut Downbenzinga.com
Sen. Elizabeth Warren (D-Mass.) urged Congress to implement stricter regulations on digital assets on Wednesday, citing concerns over President Donald Trump’s “superhighway of crypto corruption.”
Via Benzinga · July 10, 2025
Globe Life (GL): Buy, Sell, or Hold Post Q1 Earnings?
Since January 2025, Globe Life has been in a holding pattern, posting a small return of 4.6% while floating around $117.60.
Via StockStory · July 10, 2025
3 Reasons We Love Pathward Financial (CASH)
Pathward Financial currently trades at $83.75 and has been a dream stock for shareholders. It’s returned 377% since July 2020, blowing past the S&P 500’s 96.5% gain. The company has also beaten the index over the past six months as its stock price is up 16% thanks to its solid quarterly results.
Via StockStory · July 10, 2025
3 Reasons to Sell NYT and 1 Stock to Buy Instead
The New York Times trades at $55.32 per share and has stayed right on track with the overall market, gaining 8.9% over the last six months. At the same time, the S&P 500 has returned 7.5%.
Via StockStory · July 10, 2025
3 Big Reasons to Love W. R. Berkley (WRB)
Since July 2020, the S&P 500 has delivered a total return of 96.5%. But one standout stock has nearly doubled the market - over the past five years, W. R. Berkley has surged 177% to $71.14 per share. Its momentum hasn’t stopped as it’s also gained 25.5% in the last six months, beating the S&P by 18%.
Via StockStory · July 10, 2025
Blink Charging (BLNK): Buy, Sell, or Hold Post Q1 Earnings?
What a brutal six months it’s been for Blink Charging. The stock has dropped 34.6% and now trades at $1.02, rattling many shareholders. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Via StockStory · July 10, 2025
3 Reasons RNST is Risky and 1 Stock to Buy Instead
Renasant has had an impressive run over the past six months as its shares have beaten the S&P 500 by 5.3%. The stock now trades at $38.20, marking a 12.9% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Via StockStory · July 10, 2025
3 Reasons to Sell IPG and 1 Stock to Buy Instead
Over the past six months, Interpublic Group’s shares (currently trading at $24.86) have posted a disappointing 6.7% loss, well below the S&P 500’s 7.5% gain. This might have investors contemplating their next move.
Via StockStory · July 10, 2025
3 Big Reasons WTFC Should Be On Your Watchlist
Since January 2025, Wintrust Financial has been in a holding pattern, posting a small return of 4.5% while floating around $130.24.
Via StockStory · July 10, 2025
Evoke Pharma Stock Skyrockets On Patent For Nasal Spray That Eases Stomach Delays; Retail Bulls Pile Instocktwits.com
The newly allowed patent covers the use of Gimoti in patients with moderate to severe gastroparesis and is expected to extend market exclusivity through 2036.
Via Stocktwits · July 9, 2025
S&P 500’s Recovery At Risk? US Stock Futures Fall Amid Tariff Anxiety, But Strategist Says ‘Summer Surprise Rally Will Continue’stocktwits.com
ConAgra (CAG), Delta Air Lines (DAL), Helen of Troy (HELE), Levi Strauss (LEVI), and WD-40 (WDFC) are among the notable names reporting earnings Thursday.
Via Stocktwits · July 9, 2025
Trump Slaps Brazil With A 50 Percent Tariff Over Treatment Of Political Allytalkmarkets.com
The tariff Bizarro World gets more bizarre. Trump’s Letter to Brazil posted on Truth Social also moans about trade imbalances.
Via Talk Markets · July 9, 2025
Sunrun Stock Rises After Jefferies Upgrades On ‘Less Than Feared’ Impact Of Trump Policiesstocktwits.com
According to TheFly, the brokerage also raised the price target for the stock to $11 from $5.
Via Stocktwits · July 9, 2025
Unpacking Q1 Earnings: Columbia Banking System (NASDAQ:COLB) In The Context Of Other Regional Banks Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how regional banks stocks fared in Q1, starting with Columbia Banking System (NASDAQ:COLB).
Via StockStory · July 9, 2025
Unpacking Q1 Earnings: Haemonetics (NYSE:HAE) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Haemonetics (NYSE:HAE) and the best and worst performers in the medical devices & supplies - specialty industry.
Via StockStory · July 9, 2025
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q1 Earnings: QuidelOrtho (NASDAQ:QDEL) Vs The Rest Of The Pack
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - imaging, diagnostics stocks, including QuidelOrtho (NASDAQ:QDEL) and its peers.
Via StockStory · July 9, 2025
Spotting Winners: AECOM (NYSE:ACM) And Engineering and Design Services Stocks In Q1
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the engineering and design services stocks, including AECOM (NYSE:ACM) and its peers.
Via StockStory · July 9, 2025
Property & Casualty Insurance Stocks Q1 Highlights: Skyward Specialty Insurance (NASDAQ:SKWD)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Skyward Specialty Insurance (NASDAQ:SKWD) and the rest of the property & casualty insurance stocks fared in Q1.
Via StockStory · July 9, 2025
Q1 Earnings Roundup: Valmont (NYSE:VMI) And The Rest Of The Building Materials Segment
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the building materials industry, including Valmont (NYSE:VMI) and its peers.
Via StockStory · July 9, 2025
Q1 Earnings Highlights: Starwood Property Trust (NYSE:STWD) Vs The Rest Of The Thrifts & Mortgage Finance Stocks
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the thrifts & mortgage finance stocks, including Starwood Property Trust (NYSE:STWD) and its peers.
Via StockStory · July 9, 2025
Modern Fast Food Stocks Q1 Results: Benchmarking Chipotle (NYSE:CMG)
Let’s dig into the relative performance of Chipotle (NYSE:CMG) and its peers as we unravel the now-completed Q1 modern fast food earnings season.
Via StockStory · July 9, 2025
Money Has Finally Even Started Returning To The Junior Mining Explorers & Developerscontent/com
Wednesday was a mixed session for the gold and silver prices. The gold market rallied throughout the day to finish at $3,326.
Via Talk Markets · July 9, 2025
Professional Tools and Equipment Stocks Q1 Recap: Benchmarking Kennametal (NYSE:KMT)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at professional tools and equipment stocks, starting with Kennametal (NYSE:KMT).
Via StockStory · July 9, 2025
Unpacking Q1 Earnings: Somnigroup (NYSE:SGI) In The Context Of Other Home Furnishings Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Somnigroup (NYSE:SGI) and the best and worst performers in the home furnishings industry.
Via StockStory · July 9, 2025
Q1 Rundown: Hartford (NYSE:HIG) Vs Other Insurance Stocks
Looking back on insurance stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Hartford (NYSE:HIG) and its peers.
Via StockStory · July 9, 2025
Property & Casualty Insurance Stocks Q1 Recap: Benchmarking Old Republic International (NYSE:ORI)
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the property & casualty insurance stocks, including Old Republic International (NYSE:ORI) and its peers.
Via StockStory · July 9, 2025
Reflecting On Home Furnishing and Improvement Retail Stocks’ Q1 Earnings: Floor And Decor (NYSE:FND)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Floor And Decor (NYSE:FND) and the best and worst performers in the home furnishing and improvement retail industry.
Via StockStory · July 9, 2025
Q1 Earnings Highlights: Ladder Capital (NYSE:LADR) Vs The Rest Of The Thrifts & Mortgage Finance Stocks
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the thrifts & mortgage finance industry, including Ladder Capital (NYSE:LADR) and its peers.
Via StockStory · July 9, 2025
Spotting Winners: Pinnacle Financial Partners (NASDAQ:PNFP) And Regional Banks Stocks In Q1
Let’s dig into the relative performance of Pinnacle Financial Partners (NASDAQ:PNFP) and its peers as we unravel the now-completed Q1 regional banks earnings season.
Via StockStory · July 9, 2025
Melinda French Gates Reveals Why She Won't Fund Her Daughter's Startup, Says Others Should Back It If Its A 'Real Business'benzinga.com
Melinda French Gates won't fund daughter's fashion-tech venture, believing it must prove itself like any real business. Tough love for women in tech.
Via Benzinga · July 9, 2025
Natco Pharma Breaks Out On Weekly Chart: SEBI RA Rajneesh Sharma Sees Over 40% Potential Upsidestocktwits.com
The company, which is developing the generic version of Ozempic with Mylan Pharmaceuticals, has a strong fundamental outlook supported by a bullish technical setup.
Via Stocktwits · July 9, 2025
Tesla Robotaxi Could Hit San Francisco Streets In 1–2 Months, Musk Saysstocktwits.com
With its entry into California, Tesla is stepping into the backyard of Alphabet Inc.-backed Waymo.
Via Stocktwits · July 9, 2025
GDP Impact Of 87.5k Removals/Yrtalkmarkets.com
PCE inflation is 15 bps and 6 bps higher in 2026 and 2027 under the baseline.
Via Talk Markets · July 9, 2025
Market Monitor News July 10 BMO (AES Corporation, Penguin Solutions UP - AEHR Test Systems DOWN)chartmill.com
Wall Street Stays Euphoric While Trump Throws Trade Bombs: Why Investors Shrugged It Off
Via Chartmill · July 9, 2025